Obesity — Impact of Plasma Soluble Prorenin Receptor in Obese and Type 2 Diabetic Patients
Citation(s)
Achard V, Tassistro V, Boullu-Ciocca S, Grino M Expression and nutritional regulation of the (pro)renin receptor in rat visceral adipose tissue. J Endocrinol Invest. 2011 Dec;34(11):840-6. doi: 10.3275/7627. Epub 2011 Apr 6.
Cousin C, Bracquart D, Contrepas A, Corvol P, Muller L, Nguyen G Soluble form of the (pro)renin receptor generated by intracellular cleavage by furin is secreted in plasma. Hypertension. 2009 Jun;53(6):1077-82. doi: 10.1161/HYPERTENSIONAHA.108.127258. Epub 2009 Apr 20.
Deinum J, Rønn B, Mathiesen E, Derkx FH, Hop WC, Schalekamp MA Increase in serum prorenin precedes onset of microalbuminuria in patients with insulin-dependent diabetes mellitus. Diabetologia. 1999 Aug;42(8):1006-10. Erratum in: Diabetologia 1999 Dec;42(12):1444.
Hu E, Kim JB, Sarraf P, Spiegelman BM Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma. Science. 1996 Dec 20;274(5295):2100-3.
Nguyen G, Delarue F, Berrou J, Rondeau E, Sraer JD Specific receptor binding of renin on human mesangial cells in culture increases plasminogen activator inhibitor-1 antigen. Kidney Int. 1996 Dec;50(6):1897-903.
Nguyen G, Muller DN The biology of the (pro)renin receptor. J Am Soc Nephrol. 2010 Jan;21(1):18-23. doi: 10.1681/ASN.2009030300. Epub 2009 Nov 16. Review.
Schwartz J, Bashian C, Kushnir L, Nituica C, Slotman GJ Variation in Clinical Characteristics of Women versus Men Preoperative for Laparoscopic Roux-en-Y Gastric Bypass: Analysis of 83,059 Patients. Am Surg. 2017 Sep 1;83(9):947-951.
Sharples AJ, Mahawar K, Cheruvu CVN Systematic review and retrospective validation of prediction models for weight loss after bariatric surgery. Surg Obes Relat Dis. 2017 Nov;13(11):1914-1920. doi: 10.1016/j.soard.2017.08.009. Epub 2017 Aug 12. Review.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
